1. Home
  2. EYE vs BCAX Comparison

EYE vs BCAX Comparison

Compare EYE & BCAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYE
  • BCAX
  • Stock Information
  • Founded
  • EYE 1990
  • BCAX 2018
  • Country
  • EYE United States
  • BCAX United States
  • Employees
  • EYE N/A
  • BCAX N/A
  • Industry
  • EYE Ophthalmic Goods
  • BCAX
  • Sector
  • EYE Health Care
  • BCAX
  • Exchange
  • EYE Nasdaq
  • BCAX NYSE
  • Market Cap
  • EYE 911.9M
  • BCAX 1.0B
  • IPO Year
  • EYE 2017
  • BCAX 2024
  • Fundamental
  • Price
  • EYE $11.45
  • BCAX $17.21
  • Analyst Decision
  • EYE Buy
  • BCAX Strong Buy
  • Analyst Count
  • EYE 3
  • BCAX 5
  • Target Price
  • EYE $14.00
  • BCAX $41.33
  • AVG Volume (30 Days)
  • EYE 1.4M
  • BCAX 342.9K
  • Earning Date
  • EYE 11-06-2024
  • BCAX 11-12-2024
  • Dividend Yield
  • EYE N/A
  • BCAX N/A
  • EPS Growth
  • EYE N/A
  • BCAX N/A
  • EPS
  • EYE N/A
  • BCAX N/A
  • Revenue
  • EYE $2,177,092,000.00
  • BCAX N/A
  • Revenue This Year
  • EYE N/A
  • BCAX N/A
  • Revenue Next Year
  • EYE $2.80
  • BCAX N/A
  • P/E Ratio
  • EYE N/A
  • BCAX N/A
  • Revenue Growth
  • EYE 20.66
  • BCAX N/A
  • 52 Week Low
  • EYE $9.56
  • BCAX $17.00
  • 52 Week High
  • EYE $24.11
  • BCAX $28.09
  • Technical
  • Relative Strength Index (RSI)
  • EYE 48.84
  • BCAX N/A
  • Support Level
  • EYE $11.23
  • BCAX N/A
  • Resistance Level
  • EYE $11.83
  • BCAX N/A
  • Average True Range (ATR)
  • EYE 0.52
  • BCAX 0.00
  • MACD
  • EYE -0.07
  • BCAX 0.00
  • Stochastic Oscillator
  • EYE 32.34
  • BCAX 0.00

About EYE National Vision Holdings Inc.

National Vision Holdings Inc is an optical retailer in the U.S. Its product portfolio includes eyeglasses and sunglasses, contact lenses, accessories, and other products. The company has two operating segments; Owned and Host segment includes company-owned brands America's Best and Eyeglass World, In America's Best stores, vision care services are provided by optometrists or by independent professional corporations and Host operating consist of Military and Fred Meyer which provide eye exams by independent optometrists, and the Legacy segment manages the operations of, and supplies inventory and lab processing services to Legacy retail Vision Centers. It earns a majority of its revenue from the Owned and Host segment.

About BCAX BICARA THERAPEUTICS INC

Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.

Share on Social Networks: